期刊文献+

经皮二尖瓣球囊扩张术后血浆B型钠尿肽水平的变化 被引量:2

Changes of plasma B-type natriuretic peptide after percutanouse balloon mitral valvuloplasty
原文传递
导出
摘要 目的:观察心房压力快速变化对血浆B型钠尿肽(BNP)水平的影响。方法:采用床边快速BNP试验法检测30例成功施行二尖瓣球囊扩张术(PBMV)的风湿性二尖瓣狭窄患者术前、术后20min及术后24h血浆BNP浓度,与正常对照组(8例)比较,并将患者血浆BNP浓度与平均左房压(mLAP)等血流动力学参数作相关分析。结果:术前,二尖瓣狭窄患者血浆BNP水平显著高于正常对照组[(123.55±69.49)ng/L∶(16·39±7·64)ng/L,P<0·01)];且与mLAP呈显著正相关(r=0·441,P<0·05);BNP浓度在心房颤动(房颤)患者与窦性心律患者间差异无统计学意义(P>0·05)。术后,房颤患者血浆BNP浓度无明显改变[术前(111.62±53.41)ng/L,术后20min(122.04±68.70)ng/L,术后24h(106.11±56.19)ng/L,两两比较P>0·05];而窦律患者有显著下降[术前(128.66±75.96)ng/L,术后20min(88.59±61.99)ng/L,术后24h(43.39±26.70)ng/L,两两比较P<0·05)]。窦律患者中,术后20min的BNP变化(ΔBNP)与mLAP变化(ΔmLAP)呈显著正相关(r=0·696,P<0·01);术后24h的BNP变化(ΔBNP')与二尖瓣口面积(MVA)的扩大值(ΔMVA)及左房内径(LAD)的变化(ΔLAD)无相关性(分别r=0·048,P>0·05;r=-0·070,P>0·05)。结论:二尖瓣狭窄患者血浆BNP水平的升高和左房压升高显著相关。BNP是反映窦律患者球囊扩张术后左房压变化的敏感指标。 Objective: To assess the effect of acute changes in left atrial pressure on plasma B-type natriuretic peptide (BNP) levels. Method.Thirty patients of rheumatic mitral stenosis treated by percutaneouse balloon mitral valvuloplasty (PBMV) were included in this study. Plasma BNP concentrations were measured by the Triage BNP Test in all patients before, at 20 minutes and 24 hours after PBMV, and in eight healthy volunteers. The relations between BNP concentrations and mean left atrial pressure (mLAP) and other hemodynamic parameters were stud ied. Result:Plasma BNP levels in patients were significantly higher than those in the control group ([123.55±69.49]ng/L : [16.39±7.64]ng/L, P %0. 01), and basal plasma BNP level was significantly correlated with basal mean left atrial pressure (mLAP) ( r =0. 441, P 〈0. 05). But there was no difference in BNP concentrations between patients with sinus rhythm (SR) and patients with atrial fibrillation (AF) ( P 〉0.05). Plasma BNP levels remained unchanged in patients with AF after PBMV (before, [111. 62±53.41]ng/L; at 20 minutes, [122.04±68.70]ng/L; at 24 hours, [106.11±56.19]ng/L; respectively, P ;〉0.05), whereas it decreased significantly inpatients with SR after the procedure(before,[128.66 ± 75.96]ng/L;at 20 minutes, [88.58±61. 99]ng/L; at 24 hours, [43. 39±26.70]ng/L; respectively, P 〈0.05). In SR patients, there was a positive correlation between changes in plasma BNP at 20 minutes (ABNP) and changes in mean left atrial pressure (AmLAP) ( r 0. 696, P〈0.01). No relationships were observed between changes in BNP level at 24 hours (ABNP') and those in left atrial diameter (ALAD) or in mitral valve area (AMVA) ( r =0. 048, P 〉0.05; r =-0. 070, P 〉0.05, respectively). Conclusion:These results indicate that high BNP level is associated with high left atrial pressure in mitral stenosis patients. BNP may be a valid marker to reflect changes in mLAP after PBMV in sinus rhythm patients.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2006年第2期79-82,共4页 Journal of Clinical Cardiology
关键词 二尖瓣狭窄 经皮二尖瓣球囊扩张术 B型钠尿肽 Mitral stenosis Percutaneouse balloon mitral valvuloplasty B-type natriuretic peptide
  • 相关文献

参考文献20

  • 1MOHAN J C, NAIR M, ARORA R. Left ventricular volumes and function immediately after balloon mitral valvoplasty[J]. Int J Cardiol, 1991, 33: 275- 280.
  • 2HARRISON J K, DAVIDSON C J, HERMILLER J B, et al. Left ventricular filling and ventricular diastolic performance after percutaneous balloon mitral valvulotomy[J]. Am J Cardiol,1992,69:108-112.
  • 3PAMIR G, ERTAS F, ORAL D, et al. Left ventricular filling and ejection fraction after successful percutaneous balloon mitral valvuloplasty[J]. Int J Cardiol,1997,59:243-246.
  • 4THARAUX P L, DUSSAULE J C, HUBERT-BRIERRE J, et al. Plasma atrial and brain natriuretic peptides in mitral stenosis treated by valvulotomy[J].Clin Sci (Lond) ,1994,87:671-677.
  • 5NAGAYA N, NISHIKIMI T, OKANO Y, et al.Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension [J]. J Am Coll Cardiol,1998,31:202-208.
  • 6MATSUO K, NISHIKIMI T, YUTANI C, et al. Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia[J]. Circulation,1998,98:2433-2440.
  • 7YOSHIMURA M, YASUE H, OKUMURA K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure[J], Circulation, 1993,87 : 464-469.
  • 8MATSUMOTO A, HIRATA Y, MOMOMURA S,et al. Effects of exercise on plasma level of brain natriuretic peptide in congestive heart failure with and without left ventricular dysfunction[J]. Am Heart J,1995,129:139-145.
  • 9NAKAMURA M, KAWATA Y, YOSHIDA H, et al. Relationship between plasma atrial and brain natriuretic peptide concentration and hemodynamic parameters during percutaneous transvenous mitral valvulotomy in patients with mitral stenosis[J]. Am Heart J,1992,124:1283- 1288.
  • 10TUINENBURG A E, BRUNDEL B J, VAN GELDER I C, et al.Gene expression of the natriuretic peptide system in atrial tissue of patients with paroxysmal and persistent atrial fibrillation[J]. J Cardiovasc Electrophysiol, 1999,10 : 827 - 835.

同被引文献12

  • 1GOLBASY Z, UCAR O, YUKSEI A G, et al. Plasma brain natriuretic peptide levels in patients with rheumatic heart disease[J]. Eur J Heart Fail, 2004,6: 757--760.
  • 2ERDEM D, SINAN A, MURAT O, et al. Preva- lence and predictors of atrial fibrillation in rheumatic valeular heart disease[J]. Am J Cardiol,1996, 77:96 --98.
  • 3INOUE S, MURAKAMI Y, SANO K, et al. Atrium as a source of brain natriuretic peptide with fibrillation [J]. J Card Fail,2000,6:92--96.
  • 4OHTA Y, SHIMADA T, YOSHITONI H, et al. Drop in plasma brain natriuretic peptide levels after successful direct current cardioversion in chronic atrial fibrillation[J]. Can J Cardol, 2001, 17:415--420.
  • 5SHIMIZU H, MURAKAMI Y, INOUES, et al. High plasma brain natriuretic peptide level as a marker of risk for thromboembolism in patients with non- valvular atrial fibrillation[J]. Stroke, 2002,33 : 1005-- 1010.
  • 6IGARASHI Y, KASHIMURA K, MAKIYAMA Y, et al. Left atrial appendage dysfunction in chronic nonvalvular atrial fibrillation is significantly associated with an elevated level of brain natriuretic peptide and a prothrombotic state[J]. Jpn Circ J, 2001,65: 788 - 792.
  • 7Wu AH,SmithA.Biological variation of the natriuretic peptides and their role in monitoring patients with heart failure.Eur J heart Fail,2004,6:355-358.
  • 8Bettencourt P,FerreiraA,Dias P,et al.Evaluation of brain natriuretic peptid in the diagnosis of heart failure.Cardiology,2000,93:19.
  • 9Champion HC,Skaf MW.Role of nitric oxide in the pathophysiology of heart failure.Heart Fail Rev,2003,8:35-46.
  • 10鲍慧慧,程晓曙,杨人强,吴延庆,苏海,李萍,姜醒华,程应樟,俞建华,游志刚.经皮球囊二尖瓣成形术前后心房利钠肽和脑钠肽的变化[J].中国介入心脏病学杂志,2007,15(5):262-265. 被引量:2

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部